Koyfin Home > Directory > Health Care > Acceleron Pharma > Price / Tangible Book Value

Acceleron Pharma Price / Tangible Book Value Chart (XLRN)

Acceleron Pharma annual/quarterly Price / Tangible Book Value from 2013 to 2020.
  • Acceleron Pharma Price / Tangible Book Value for the quarter ending September 09, 2020 was 14.46 a 3.90% increase of 0.56 year over year
  • Acceleron Pharma Price / Tangible Book Value for the last 12 months ending September 09, 2020 was 14.46 a 3.90% increase of 0.56 year over year
  • Acceleron Pharma Annual Price / Tangible Book Value for 2020 was 14.46 a -0.52% decrease of -0.07 from 2019
  • Acceleron Pharma Annual Price / Tangible Book Value for 2020 was 14.53 a 3.64% increase of 0.53 from 2019
  • Acceleron Pharma Annual Price / Tangible Book Value for 2020 was 14.00 a 0.78% increase of 0.11 from 2019
Other Valuation Metrics:
  • Acceleron Pharma Market Cap for the quarter ending March 03, 2018 was $1,776m a 33.91% increase of 602m year over year
  • Acceleron Pharma Price / Book for the quarter ending March 03, 2018 was 4.85 a -16.20% decrease of -0.78 year over year
  • Acceleron Pharma Enterprise Value for the quarter ending March 03, 2018 was $1,499m a 31.12% increase of 466m year over year
View Chart On Koyfin

Quarterly XLRN Price / Tangible Book Value Data

09/202014.46
09/202014.53
09/202014.00
09/202013.89
09/202013.49
09/202014.27
09/202014.05
09/202013.76
09/202013.69
09/202013.39

Annual XLRN Price / Tangible Book Value Data

202014.46
202014.53
202014.00
202013.89
202013.49
202014.27
202014.05
202013.76
202013.69
202013.39